Semasize Plus 1.7mg Injection (1 Multi-dose Disposable Pen, 4 Needle, 4 Alcohol Swab)
Semasize Plus 1.7mg is a once-weekly pre-filled multi-dose disposable pen injection designed for convenient home use. The medicine is commonly prescribed as part of a dose-escalation plan, Semasize Plus 1.7mg Injection contains Semaglutide, a GLP-1 receptor agonist used to support weight management and improve blood sugar control in adults with type 2 diabetes.
Product Overview
Semasize Plus 1.7mg Injection contains Semaglutide, a medicine that works similarly to the naturally occurring hormone GLP-1 (glucagon-like peptide-1). GLP-1 plays an important role in controlling blood sugar levels, appetite, and digestion. Semaglutide helps increase insulin release when blood glucose levels are high, reduces glucagon activity, and slows stomach emptying. These actions help improve blood sugar regulation and support reduced appetite, which may contribute to weight management.
Product Composition
- Semaglutide 1.7mg – Active ingredient
- GLP-1 receptor agonist
- Incretin-based therapy
Product Specification
| Parameter | Details |
| Product Name | Semasize Plus 1.7mg Injection |
| Active Ingredient | Semaglutide |
| Strength | 1.7mg |
| Medicine Class | GLP-1 Receptor Agonist |
| Therapeutic Use | Weight management and type 2 diabetes support |
Key Benefits
- Supports weight management:
Semaglutide helps reduce appetite and supports better control of food intake. - Helps improve blood sugar levels:
It supports insulin activity and helps maintain healthier glucose levels. - Reduces hunger cravings:
Semaglutide affects appetite-regulating pathways to help control hunger. - Improves insulin response:
It helps the body release insulin more effectively when needed. - Supports metabolic balance:
It helps improve overall glucose and energy regulation. - Convenient weekly dosing:
Semaglutide formulations are generally designed for regular scheduled use.
Precaution
| Condition / Situation | Precaution |
| Pancreas problems | Inform your healthcare provider about any history of pancreatitis or pancreatic conditions before use |
| Gallbladder problems | Discuss previous gallbladder issues, as Semaglutide may affect gallbladder function in some people |
| Kidney problems | Maintain proper hydration, especially during vomiting or diarrhoea episodes |
| Pregnancy and breastfeeding | Discuss use before pregnancy or during breastfeeding |
| Digestive problems | Use cautiously in people with severe stomach disorders |
Important Precaution Points
- Use Semasize Plus 1.7mg Injection according to the recommended dose and injection schedule.
- Follow proper injection techniques and rotate injection sites to reduce skin irritation.
- Maintain enough fluid intake, especially if nausea, vomiting, or diarrhoea occurs.
- Inform your healthcare provider about diabetes medicines, digestive problems, or thyroid-related conditions.
Side Effects
Common Side Effects
- Nausea:
Feeling of sickness is common, especially when starting or increasing the dose. - Vomiting:
Some individuals may experience vomiting or stomach discomfort. - Diarrhoea:
Changes in bowel movements may occur during treatment. - Constipation:
Slower digestion may lead to constipation in some people. - Reduced Appetite:
Decreased hunger is an expected effect of Semaglutide.
Less Common Side Effects
- Stomach pain or bloating
- Indigestion
- Injection site redness or irritation
- Tiredness
- Dizziness
Serious Side Effects
| Condition | Risk Detail |
| Severe allergic reaction | Rash, facial swelling, breathing difficulty, or severe sensitivity may occur rarely |
| Low blood sugar (Hypoglycaemia) | Risk may increase when combined with insulin or certain diabetes medicines |
| Kidney problems | Severe dehydration from vomiting or diarrhoea may affect kidney function |
Important Side Effects
- Mild nausea, constipation, or diarrhoea may occur and often improves as the body adjusts.
- Reduced appetite is a common effect that supports weight management goals.
- Temporary stomach discomfort or bloating may occur during the initial treatment period.
- Injection site irritation may occur and is usually manageable.
Interaction
| Medicine / Substance | Possible Effect |
| Insulin | May increase the risk of low blood sugar when combined with Semaglutide |
| Sulfonylureas | May increase the chance of hypoglycaemia |
| Diabetes medicines | Blood sugar-lowering effects may become stronger |
| Warfarin | Changes in absorption may require monitoring |
Important Interaction Advice
- Insulin and diabetes medicines:
Semasize Plus may increase glucose-lowering effects, so blood sugar monitoring may be needed. - Oral medicines:
Semaglutide slows stomach emptying, which may affect how quickly some tablets are absorbed. - Other weight management medicines:
Avoid combining similar GLP-1 medicines unless advised. - Blood-thinning medicines:
Inform your healthcare provider if you take anticoagulants or medicines requiring careful monitoring.
| Manufacturer | : | Alkem Laboratories Ltd |
| Trade Name | : | Ozempic |
| Generic Search | : | Semaglutide |
| Strength | : | 1.7 mg |
Certified Content
Dr. Priya Nair
Clinical Pharmacist & Senior Drug Information Specialist | 9 years
Pharm.D. (Doctor of Pharmacy)
Latest Products
